OCU410ST

· Ocugen

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OCU410ST, covering 2026-04-06 to 2026-07-31. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease [Phase 2, Phase 3]